Statistics from Altmetric.com
- long-acting progestogens
- long-acting reversible contraception
- hormonal contraception
- contraceptive implants
The current clinical guideline on progestogen-only implants produced by the Faculty of Sexual and Reproductive Health (FSRH) Clinical Effectiveness Unit was written in February 2014 and is due to be updated within the next year.
We are all familiar with the risks associated with an implant insertion which is too deep; these risks include neural or vascular damage, paraesthesia, migration, and rarely intravascular migration. Deep insertions also mean that the implant may be more difficult to remove, which may result in repeat patient appointments and additional scans or imaging, and it may be impossible to remove without an onward surgical referral.1 2
Given this, healthcare professionals (HCPs) are understandably eager to minimise the risk of deep insertion for …
Contributors RB-E researched and authored the article and prepared it for submission. KJ assisted with the manuscript draft and proof-reading. JKG suggested the topic of the letter and approved the final draft. GVB-E assisted with the anatomical information and associated reference.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Not commissioned; internally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.